Page 14 - Advanced Performance News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Morgan Stanley Lowers Chemours (NYSE:CC) Price Target to $28 00

Morgan Stanley Lowers Chemours (NYSE:CC) Price Target to $28 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Nova scotiaUnited statesAsia pacificRoyal bankSpecialized solutionsVanguard group incMorgan stanleyBlackrock incChemours company profileChemours companyYork mellon corpGet free reportNew york mellon corpState street corpStreet corpNorth america

Short Interest in The Chemours Company (NYSE:CC) Increases By 8 9%

Short Interest in The Chemours Company (NYSE:CC) Increases By 8 9%
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdom generalUnited kingdomAsia pacificYork mellon corpChemours companyBalyasny asset managementBlackrock incSpecialized solutionsMorgan stanleyRoyal bankNorges bankGet free reportNew york mellon corpAsset managementNorth america

Chemours (NYSE:CC) Price Target Cut to $28 00

Chemours (NYSE:CC – Get Free Report) had its price objective lowered by research analysts at Morgan Stanley from $33.00 to $28.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage presently has an “equal weight” rating on the specialty chemicals company’s stock. Morgan Stanley’s target price points to a potential upside […]

United statesAsia pacificEversource wealth advisorsRoyal bankSpecialized solutionsOperose advisorsAtlas capital advisorsMorgan stanleyChemours company profileAmeritas advisory servicesLegacy financial groupChemours companyGet free reportSource wealth advisorsAdvisory servicesFinancial group

Chemours (NYSE:CC) Price Target Cut to $28 00 by Analysts at Barclays

Chemours (NYSE:CC – Get Free Report) had its target price decreased by research analysts at Barclays from $31.00 to $28.00 in a research note issued on Monday, Benzinga reports. The brokerage presently has an “equal weight” rating on the specialty chemicals company’s stock. Barclays‘s price objective would indicate a potential upside of 15.99% from the […]

United statesAsia pacificRoyal bankSpecialized solutionsBaird financial group incBrown advisory incChemours companyBrown brothers harriman coMorgan stanleyGet free reportBaird financial groupFinancial groupNorth americaMiddle eastTitanium technologiesAdvanced performance

Barclays Lowers Chemours (NYSE:CC) Price Target to $28 00

Chemours (NYSE:CC – Get Free Report) had its price target reduced by equities researchers at Barclays from $31.00 to $28.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage presently has an “equal weight” rating on the specialty chemicals company’s stock. Barclays‘s target price points to a potential upside of 15.99% […]

United statesAsia pacificA davidsonRaymond james associatesRoyal bankSpecialized solutionsMorgan stanleyChemours companyMetlife investment managementCetera advisor networksGet free reportAdvisor networksMontreal canLife investment managementNorth americaMiddle east